Cargando…
Delayed Response After Confirmed Progression (DR) and Other Unique Immunotherapy-Related Treatment Concepts in Cutaneous Squamous Cell Carcinoma
Non-melanoma skin cancers are one of the most common cancers diagnosed worldwide, with the highest incidence in Australia and New Zealand. Systemic treatment of locally advanced and metastatic cutaneous squamous cell carcinomas has been revolutionized by immune checkpoint inhibition with PD-1 blocka...
Autores principales: | Lim, Annette M., Cavanagh, Karda, Hicks, Rodney J., McLean, Luke, Goh, Michelle S., Webb, Angela, Rischin, Danny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081898/ https://www.ncbi.nlm.nih.gov/pubmed/33937066 http://dx.doi.org/10.3389/fonc.2021.656611 |
Ejemplares similares
-
Immunotherapy to Avoid Orbital Exenteration in Patients With Cutaneous Squamous Cell Carcinoma
por: McLean, Luke S., et al.
Publicado: (2022) -
FDG-PET/CT imaging for evaluating durable responses to immune check point inhibitors in patients with advanced cutaneous squamous cell carcinoma
por: McLean, Luke S., et al.
Publicado: (2021) -
Biology and Treatment Advances in Cutaneous Squamous Cell Carcinoma
por: Thai, Alesha A., et al.
Publicado: (2021) -
Immunotherapy in oncogene addicted non-small cell lung cancer
por: McLean, Luke, et al.
Publicado: (2021) -
Confirmed Efficacy of Lenalidomide and Dexamethasone in Unresectable Cutaneous Facial Rosai-Dorfman-Destombes Disease
por: Al-Ghawas, Mae S., et al.
Publicado: (2019)